[Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia]
| Autor: | N M, Kadysheva, A N, Mokhovikov, K V, Mosketi, G N, Kryzhanovskiĭ |
|---|---|
| Rok vydání: | 1988 |
| Předmět: |
Adult
Male Niacinamide Benzodiazepinones Adolescent Psychopathology Compulsive Personality Disorder alpha-Tocopherol Tocopherols Lithium Middle Aged Personality Disorders Benzodiazepines Anti-Anxiety Agents Pyridoxal Phosphate Chronic Disease Schizophrenia Drug Evaluation Haloperidol Humans Vitamin E Drug Therapy Combination Female Aged |
| Zdroj: | Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). 88(10) |
| ISSN: | 0044-4588 |
| Popis: | The effectiveness of combined phenazepam, lithium, haloperidol and metabolic drugs (alpha-tocopherol, pyridoxal phosphate, nicotinamide) treatment of patients with slow progredient schizophrenia is analyzed. The psychotropic drugs were administered at doses lower below mean therapeutic ones by 1/2 to 1/3. Combined therapy proved effective even in the cases resistant to active antipsychotic treatment. No considerable untoward effects (extrapyramidal disorders) were found. The therapy had a differentiated impact on the obsessive syndrome and other borderline psychopathologic states. These advantages allow one to recommend the therapy for long-term support in schizophrenic patients with benign course of the disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|